- JP-listed companies
- Cuorips Inc.
- Balance sheet
Cuorips Inc. (4894) Balance sheet
Market cap
¥57B
P/E ratio
-58.6x
Qualips develops regenerative medicine treatments using human iPS cells, specializing in cardiac muscle cell sheets for severe heart failure patients.
| 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Cash and cash equivalents | - | 3,542 | 3,342 | 2,942 | 5,561 | 4,595 |
| Marketable securities, current | - | - | - | - | 21 | 199 |
| Total cash & short-term investments | - | 3,542 | 3,342 | 2,942 | 5,582 | 4,794 |
| Total current assets | - | 3,619 | 3,367 | 2,977 | 5,612 | 5,125 |
| Property, plant and equipment, net | - | 702 | 634 | 562 | 514 | 515 |
| Total non-current assets | - | 746 | 678 | 610 | 573 | 616 |
| Total assets | - | 4,364 | 4,045 | 3,587 | 6,185 | 5,742 |
| Total current liabilities | - | 104 | 112 | 97 | 166 | 177 |
| Total non-current liabilities | - | 38 | 37 | 36 | 35 | 35 |
| Total liabilities | - | 142 | 149 | 134 | 201 | 212 |
| Retained earnings | - | -643 | -1,018 | -1,470 | -2,102 | -2,746 |
| Stockholders' equity | 750 | 4,222 | 3,896 | 3,454 | 5,984 | 5,530 |